- Home
- OGI vs HUMA Comparison
OGI vs HUMA Comparison
Compare OGI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | HUMA |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.3M | 165.7M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OGI | HUMA |
|---|---|---|
| Price | $0.93 | $0.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $2.39 | $1.63 |
| AVG Volume (30 Days) | 447.7K | ★ 5.6M |
| Earning Date | 08-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | $34.95 | $72.32 |
| Revenue Next Year | $30.97 | $518.79 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $0.34 |
| 52 Week High | $2.24 | $1.90 |
Technical Indicators
Market Signals| Indicator | OGI | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 39.73 |
| Support Level | $0.92 | N/A |
| Resistance Level | $1.07 | $0.75 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 15.67 | 47.46 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.